Evidence map›Paper›PMID 41535587›Full record

ArticleArchives of toxicology2026

Arsenic disrupts autophagosome-lysosome fusion in a zinc dependent manner across multiple human skin and lung cells lines.

Rachel V Goff, Sidimohamed Elmoustapha, Shelia D Thomas, Mayukh Banerjee

Abstract read
In one paragraph

Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rachel V Goff *Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.ORCID 0009-0007-5402-3485
Sidimohamed Elmoustapha *Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.ORCID 0009-0001-3767-0708
Shelia D ThomasDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA.ORCID 0000-0002-1892-3765
Mayukh BanerjeeDepartment of Pharmacology and Toxicology, University of Louisville, Louisville, KY, 40202, USA. mayukh.banerjee@louisville.edu.ORCID 0000-0003-3028-1192

Funding

University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
Summer Environmental Health Sciences Training ProgramT35ES014559 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Matthew C Cave, Daniel Joseph Conklin · 2006 to 2026
$751k
American Cancer Society DBG-23-1143457-01-CDPJewish Heritage Fund for Excellence Research Enhancement Grant Program at the University of Louisville, School of Medicine Jewish Heritage Fund for Excellence Research Enhancement Grant Program at the University of Louisville, School of MedicineNIEHS NIH HHS P30 ES030283NIEHS NIH HHS P30ES030283NIEHS NIH HHS T35 ES014559NIEHS NIH HHS T35ES014559
6 · The paper itself

Abstract

Chronic environmental arsenic exposure causes skin and lung cancers, but the molecular mechanisms are poorly understood. We identified that chronic trivalent inorganic arsenite (iAs) exposure at population relevant 100 nM concentration activates autophagy while suppressing downstream protein degradation. Here, we studied the mechanisms by which environmental iAs exposure uncouples autophagy activation from autophagic protein degradation across human skin and lung cell lines. During autophagy, zinc regulates the critical autophagosome-lysosome fusion (ALF) step connecting initiation to final protein degradation. iAs disrupts zinc dependent processes. Thus, we hypothesized that iAs suppresses autophagy by compromising ALF. We demonstrate that environmental 100 nM iAs exposure specifically targets the ALF step of autophagy to suppress autophagic protein degradation across multiple skin and lung cell line models. We show that iAs suppresses ALF in a zinc dependent manner. Physiological zinc supplementation (1 μM) prevented and rescued against iAs-induced suppression of ALF and autophagic protein degradation in the short and long-term. Our work provides a framework to understand and further investigate the precise molecular mechanisms by which chronic environmental iAs exposure disrupts global protein degradation, thereby inducing proteotoxicity across multiple target tissues and contributing to the observed proteome-wide differential expression patterns during multi-organ carcinogenesis.

Indexed as

ArsenicArsenitesAutophagosomesLungLysosomesSkinZincAutophagyCell LineHumansMembrane FusionProteolysisArsenicArsenitesZincArsenicAutophagosome–lysosome fusionAutophagyProtein degradationZinc

Identifiers

PMID41535587
PMCPMC12818535

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.